Abstract
REPORT HIGHLIGHTS
- The global market for pain management pharmaceuticals and devices amounted
to $19.1 billion in 2008 and is expected to increase to $32.8 billion in 2013.
The compound annual growth rate (CAGR) for the 5-year period is projected at
11.5%.
- The pharmaceuticals segment dominated the market at $17.6 billion in 2008.
That figure is expected to increase to $30.2 billion in 2013, for a CAGR of
11.5%.
- The devices segment of the market generated $1.48 billion in sales in 2008
and is projected to increase to $2.5 billion in 2013, for a CAGR of 11.4%.
|
Related Report
|